|
|
|
| |
|
|
| |
The latest gastroenterology news from News Medical |
|
|
|
 | | |  How diet influences the gut microbiome and overall health Discover how everyday dietary choices rapidly reshape your gut microbiome and, over time, influence inflammation, metabolism, and long-term disease risk. | | | | |  Rare sugars vs. regular sugar: Which is better for glucose control? Rare sugars such as allulose and tagatose may help blunt post-meal glucose rises while offering sweetness and food functionality closer to regular sugar. Current evidence is promising but still limited by small, short-term human studies. | | | | |  GLP-1 drugs promise wider health benefits, but experts urge caution on use GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, with evidence for glycemic, weight-loss, cardiovascular, and renal benefits. The review urges nurse practitioners to balance expanding clinical promise with careful prescribing, patient education, monitoring, access advocacy, and vigilance for gastrointestinal, endocrine, pregnancy-related, and rare serious risks. | |
|
|
| | | | | A protein long understood to drive inflammation by producing nitric oxide has a second, previously unknown role - it physically binds to another key protein inside cells to directly modulate the immune response. | | | | | Researchers at the School of Medicine at the University of California, Riverside have discovered previously unrecognized immune surveillance structures in the skin. | | | | | An experimental drug may in future provide a new form of protection for people with celiac disease. | | | | | Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences. | | | | | The American Gastroenterological Association (AGA) has released a new clinical practice update providing expert guidance on the diagnosis and treatment of hemorrhoids, a common condition affecting approximately 50% of people by age 50. | |
|
|
|
|
|
|
|
